Hematology Activities
Advances in the Management of Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Nontransplant Candidates
0290-0000-20-333-H01-P
This activity will explore the clinical data associated with the treatment of R/R DLBCL and will also highlight the mechanism of action, potential drug interactions, and adverse effects associated with mAb and antibody-drug conjugate therapies.
1.00
Safety and Efficacy Updates of Specific DOAC Reversal Agents: New Data and Real-World Evidence, featuring Patient Cases
0290-0000-20-396-H01-P
The activity will explore the most recent guidelines and recommendations for the reversal of major bleeding associated with the use of direct oral anticoagulants (DOACs)
1.00
A New Advent in Hemophilia: Healthcare Economics Associated With Emerging Gene Therapies
0290-0000-20-381-H01-P
This webinar will examine the clinical and economic impact of acute and long-term bleeding events for patients with hemophilia.
1.00
Treating Anemia in Patients With Chronic Kidney Disease on Dialysis: The Role of the Pharmacist
0290-0000-20-378-H01-P
This webinar will assist pharmacists caring for patients with CKD and anemia on dialysis in their traditional roles of medication management and patient monitoring and counseling.
1.00